Blomia Tropicalis (Blo t 10) IgE

If your allergy testing comes back positive for dust mites but the picture doesn't quite fit your symptoms, this test can help explain why. Blo t 10 (full name: Blomia tropicalis allergen 10) is a single protein from a mite that predominates in tropical and subtropical homes, and an antibody response to it tends to travel with a much broader pattern of allergy across shellfish, roundworms, and other mites.

That broader pattern matters. In one study of asthmatic adults in a tropical region, people with strong antibody responses to this protein and similar proteins had more severe asthma and more emergency visits. Knowing whether you carry this kind of cross-reactive antibody profile can reframe what your allergy actually is and how aggressively you should manage it.

What This Test Actually Measures

The test detects IgE (immunoglobulin E) antibodies in your blood that bind to Blo t 10. IgE is the antibody class your immune system makes when it treats something harmless as a threat. Blo t 10 itself is a tropomyosin, a structural protein that makes up part of the muscle and movement machinery in mites, shrimp, crab, cockroaches, and parasitic roundworms. Blomia tropicalis has 26 officially accepted allergens, and Blo t 10 is one of the cross-reactive ones rather than the most common.

Because tropomyosin looks almost identical across these very different creatures, an IgE response that started against one of them often reacts to all of them. In a Colombian study of asthmatic adults, IgE responses to Blo t 10, the equivalent house dust mite protein (Der p 10), and the parasitic roundworm Ascaris tropomyosin (Asc l 3) clustered together as a recognized cross-reactive group, and around 26% of these asthma patients had IgE against Blo t 10. Earlier work using inhibition experiments confirmed that antibodies against Blomia and Ascaris tropomyosin can block each other, consistent with strong structural overlap.

This is a Tier 3 marker, meaning it is used mainly in component-resolved allergy research and specialty allergy workups rather than in routine primary care. There are no universally standardized cutoff numbers for what counts as a clinically meaningful level. Interpreting your result depends on the pattern across other component tests and on your symptoms.

Asthma Severity

In a tropical asthma cohort, IgE to cross-reactive tropomyosins from house dust mite and Ascaris was associated with worse disease. Sensitization to these tropomyosins was linked to having more than four asthma-related emergency visits per year, with an adjusted odds ratio of about 2.2. The published analysis grouped tropomyosins together rather than singling out Blo t 10 alone, so the signal applies to the broader cross-reactive response rather than to this one protein in isolation.

If your asthma is poorly controlled despite standard treatment, a positive Blo t 10 result combined with strong responses to Der p 10 or Asc l 3 can suggest that a wide, cross-reactive sensitization is contributing. That is useful information for an allergist when planning more targeted treatment.

Cross-Reactivity With Shellfish and Roundworms

Because Blo t 10 shares its structure with shellfish tropomyosin and parasitic worm tropomyosin, a positive result can flag the possibility of cross-reactive symptoms beyond house dust. Studies measuring IgE to these proteins consistently find them moving together. This test does not diagnose shellfish allergy on its own, but the result is one input into a broader cross-reactivity picture.

A Different Kind of Mite Allergy Signal

Blo t 10 is not the main allergen most Blomia-sensitized people react to. Across multiple regional cohorts, the major Blomia allergens Blo t 5, Blo t 21, Blo t 2, and Blo t 7 dominate the IgE response, and Blo t 10 is typically recognized by a much smaller share of patients. Malaysian data, for example, show sensitization rates of roughly 75% to Blo t 5, 58% to Blo t 21, 57% to Blo t 2, and 83% to Blo t 7, while tropomyosin sits well below these in most populations.

This is why a negative Blo t 10 result does not rule out Blomia allergy. The test is specifically useful for identifying a tropomyosin-driven, cross-reactive pattern that you would miss if you only looked at the dominant Blomia components or the house dust mite extract.

Why One Reading Is Not Enough

Allergen-specific IgE is not a static number. In a Colombian birth cohort, IgE responses to Blomia components shifted between ages 1 and 6, influenced by hygiene, exposure, and parasite infection. A study of inherited differences in Blomia sensitization showed that genetic background explains a moderate share (around 56%) of the difference between people, with stronger genetic effects in male children. Levels reflect a living immune response, so a single number is a snapshot.

Treat a first result as a baseline. If you start mite allergen immunotherapy, retest after roughly 6 to 12 months to see whether the antibody trajectory matches your symptom response. In a randomized trial of sublingual immunotherapy that included Blomia extract, total and mite-specific IgE were measured at 6 and 12 months, and the antibody response can be slow to shift even when symptoms improve. Annual tracking is a reasonable cadence after that, and more often if you are changing exposure (e.g., moving to a humid climate) or changing treatment.

When Results Can Be Misleading

Several things can make a single Blo t 10 reading confusing rather than clarifying.

• Cross-reactivity inflation: because tropomyosins look alike, a positive Blo t 10 may reflect an underlying response to Der p 10 (house dust mite tropomyosin), Asc l 3 (Ascaris roundworm tropomyosin), or shrimp tropomyosin rather than a true Blomia-specific allergy.
• Assay and panel quality: commercial Blomia extracts vary widely in how much of each component they contain. If your earlier mite test was done with an extract that under-represents tropomyosin, you may have been falsely reassured.
• Geographic relevance: Blomia tropicalis predominates in tropical and subtropical regions. Sensitization rates and baseline levels differ across populations, so reference ranges drawn from one region may not apply elsewhere.
• Sensitization is not the same as allergy: detectable IgE confirms that your immune system recognizes the protein but does not on its own prove that exposure causes your symptoms. Clinical history and exposure context still matter.

What to Do With an Unexpected Result

An isolated positive Blo t 10 with no symptoms is not a reason for alarm. A positive result combined with chronic asthma, allergic rhinitis, or unexplained reactions to shellfish or seafood is a reason to push further. The most useful next step is ordering or reviewing companion component tests: Der p 10 to confirm the tropomyosin pattern, the dominant Blomia components (Blo t 5, Blo t 21, Blo t 2) to gauge overall Blomia allergy, and Der p 1 and Der p 2 for the broader house dust mite picture.

If multiple tropomyosin components are positive and you have ongoing symptoms, this is the point at which an allergist or immunologist becomes valuable. They can integrate component-resolved results with exposure history, decide whether allergen immunotherapy is appropriate, and select an extract that matches your actual sensitization profile rather than guessing from a generic dust mite test.